Opko Health Other Current Assets Over Time
| OPK Stock | USD 1.58 0.02 1.28% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Opko Health Performance and Opko Health Correlation. Opko |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.19) | Revenue Per Share 0.998 | Quarterly Revenue Growth (0.03) | Return On Assets (0.09) |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Current Assets Analysis
Compare Opko Health and related stocks such as Caredx Inc, Castle Biosciences, and Twist Bioscience Corp Other Current Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDNA | 248 K | 248 K | 248 K | 255 K | 542 K | 1.3 M | 1.2 M | 1.4 M | 1.8 M | 3.6 M | 7.5 M | 15.9 M | 9.2 M | 7.8 M | 4.6 M |
| CSTL | 515.5 K | 515.5 K | 515.5 K | 515.5 K | 515.5 K | 515.5 K | 515.5 K | 515.5 K | 675.6 K | 2 M | 9.5 M | 9.6 M | 6.2 M | 6.3 M | 5.5 M |
| TWST | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.5 M | 3.5 M | 2.6 M | 12.4 M | 16.6 M | 11.9 M | 11.7 M | 11.4 M | 8.9 M |
| BDSX | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 5.5 M | 4.3 M | 3.8 M | 4.3 M | 4.1 M |
| NTRA | 355 K | 355 K | 355 K | 1.2 M | 1.3 M | 5.3 M | 7.1 M | 8.6 M | 6.2 M | 16.4 M | 26.8 M | 29.9 M | 33.6 M | 60.5 M | 63.6 M |
| FLGT | 141 K | 141 K | 141 K | 141 K | 141 K | 212 K | 322 K | 2.4 M | 314 K | 277 K | 3.7 M | 6 M | 44.5 M | 26.2 M | 27.6 M |
| ILMN | 95.8 K | 52.4 M | 63.2 M | 58.9 M | 70.6 M | 54.3 M | 77.9 M | 91 M | 78 M | 105 M | 290 M | 295 M | 536 M | 432 M | 453.6 M |
| TTOO | 140 K | 140 K | 140 K | 195 K | 1.2 M | 860 K | 820 K | 708 K | 1.3 M | 1.4 M | 2.7 M | 3.1 M | 2.6 M | 3.3 M | 1.7 M |
| A | 375 M | 341 M | 329 M | 376 M | 294 M | 189 M | 192 M | 187 M | 198 M | 216 M | 222 M | 282 M | 274 M | 246.6 M | 283.8 M |
| ME | 36.9 M | 36.9 M | 36.9 M | 36.9 M | 36.9 M | 36.9 M | 36.9 M | 36.9 M | 36.9 M | 16 M | 22.4 M | 34.4 M | 32.5 M | 11.1 M | 20.4 M |
| IDXX | 1.5 M | 66 M | 66.3 M | 82.2 M | 124.1 M | 101.9 M | 91.2 M | 101.1 M | 108.2 M | 125 M | 94.2 M | 116.6 M | 130.2 M | 131.5 M | 138.1 M |
| GH | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.5 M | 5.2 M | 11.4 M | 34.9 M | 106.1 M | 31.5 M | 27.7 M | 30.2 M |
Opko Health and related stocks such as Caredx Inc, Castle Biosciences, and Twist Bioscience Corp Other Current Assets description
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.My Equities
My Current Equities and Potential Positions
| Opko Health | OPK |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Florida; U.S.A |
| Exchange | NASDAQ Exchange |
USD 1.58
Check out Opko Health Performance and Opko Health Correlation. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Opko Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.